R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 15,000 shares at $43.74 ($659K) on 2009-11-03, disclosed to the SEC on 2009-11-04.
Scheduled sale ($659k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.74 | 9,300 | $407K | 61.7% |
| 2 | $44.26 | 5,700 | $252K | 38.3% |
| Total | $43.94 avg | 15,000 | $659K | 100% |
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |